Avantor, Inc. (AVTR)
14.26
-0.20
(-1.38%)
USD |
NYSE |
Aug 24, 16:00
14.26
0.00 (0.00%)
After-Hours: 20:00
Avantor Price to Book Value : 1.713 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 1.738 |
| August 20, 2026 | 1.712 |
| August 19, 2026 | 1.677 |
| August 18, 2026 | 1.602 |
| August 17, 2026 | 1.622 |
| August 14, 2026 | 1.641 |
| August 13, 2026 | 1.664 |
| August 12, 2026 | 1.674 |
| August 11, 2026 | 1.654 |
| August 10, 2026 | 1.650 |
| August 07, 2026 | 1.633 |
| August 06, 2026 | 1.584 |
| August 05, 2026 | 1.605 |
| August 04, 2026 | 1.644 |
| August 03, 2026 | 1.642 |
| July 31, 2026 | 1.656 |
| July 30, 2026 | 1.665 |
| July 29, 2026 | 1.728 |
| July 28, 2026 | 1.492 |
| July 27, 2026 | 1.413 |
| July 24, 2026 | 1.375 |
| July 23, 2026 | 1.364 |
| July 22, 2026 | 1.316 |
| July 21, 2026 | 1.320 |
| July 20, 2026 | 1.281 |
| Date | Value |
|---|---|
| July 17, 2026 | 1.330 |
| July 16, 2026 | 1.353 |
| July 15, 2026 | 1.346 |
| July 14, 2026 | 1.357 |
| July 13, 2026 | 1.269 |
| July 10, 2026 | 1.248 |
| July 09, 2026 | 1.263 |
| July 08, 2026 | 1.173 |
| July 07, 2026 | 1.226 |
| July 06, 2026 | 1.246 |
| July 02, 2026 | 1.24 |
| July 01, 2026 | 1.203 |
| June 30, 2026 | 1.190 |
| June 29, 2026 | 1.226 |
| June 26, 2026 | 1.256 |
| June 25, 2026 | 1.232 |
| June 24, 2026 | 1.184 |
| June 23, 2026 | 1.152 |
| June 22, 2026 | 1.142 |
| June 18, 2026 | 1.171 |
| June 17, 2026 | 1.156 |
| June 16, 2026 | 1.169 |
| June 15, 2026 | 1.186 |
| June 12, 2026 | 1.147 |
| June 11, 2026 | 1.180 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Medpace Holdings, Inc. | 39.79 |
| Champions Oncology, Inc. | 17.59 |
| Personalis, Inc. | 7.726 |
| Adaptive Biotechnologies Corp. | 28.43 |
| 10X Genomics, Inc. | 10.07 |
Price to Book Value Related Metrics
| PS Ratio | 1.475 |
| Price to Free Cash Flow | 21.29 |
| Price | 14.26 |
| Earnings Yield | -5.94% |
| Market Cap | 9.647B |
| Operating PE Ratio | 17.98 |
| Normalized PE Ratio | 1697.62 |